Unit 9 Seminar
docx
keyboard_arrow_up
School
Strayer University *
*We aren’t endorsed by this school
Course
2117L
Subject
Health Science
Date
Feb 20, 2024
Type
docx
Pages
2
Uploaded by zacharylacyclgi
Unit 9 Seminar
Chimere Martin
In Unit 9 seminar we discussed Multi Center Pain Neuroscience education trial. Participants will understand and be able to verbalize phrases to promote development of a positive therapeutic alliance. Participants will learn how to apply PNE strategies by reframing the
pain experience as an opportunity for positive change. Current evidence-based research supports a physician discussing the neurobiology and neurophysiology of a patient's pain experience. When a patient fully gets it, they have less pain, less handicap, move better, do better in rehab, have better cognitions about their pain, and have less nervous system sensitization.
◦
Multicenter, randomized, controlled trial on pre-op PNE for lumbar radiculopathy.
◦
Patients 18-65 years old scheduled for lumbar surgery (LS) for radiculopathy.
◦
Randomly assigned to 2 groups.≥ Usual Care
◦
Experimental Group
Scheduled for one 30-minute pre-op education visit during the week prior to surgery.
◦
At 1-year follow-up, there were no statistical differences between the experimental and control groups with regard to primary outcome measure of low back pain, leg pain, and function. BU
◦
In a majority of the categories regarding surgical experience, the PNE group scored significantly better:better prepared for LSPre-op session preparing them for LS and LS meeting their expectations
Health care utilization post-LS also favored the PNE group resulting in 45% less health care expenditure compared to the control group in the 1-year follow-up period.
Effect of patient's body weight and blood volume on the incidence of coagulopathy and complications in patients with pulmonary embolism treated
with systemic tPA
◦
"Blood clots in the lung"
◦
Sudden blockage in a lung artery
◦
Cause: blood clot in the leg (deep vein thrombosis)breaks loose -> bloodstream -› lung.
◦
Serious condition:
⁃
Permanent damage to the affected lung
⁃
Low oxygen levels in blood
⁃
Damage to other organs in body from not getting enough oxygen
Large clots or many clots -> Death
Hemodynamically stable patients:
◦
Blood thinners: prevent clots from forming or getting larger
⁃
Systemic anticoagulants: e.g. heparin
Major PE Risk Categories
◦
High Risk (massive) PE - patients present with hypotension, shock, or inability to maintain oxygenation
◦
Intermediate Risk (submassive) PE - patients are not hypotensive but have right heart strain on echocardiography or CT, large PE, and ^ cardiac biomarkers (troponin and/or brain natriuretic peptide, BNP)
◦
Low Risk PE - normotensive with normal biomarkers, no right ventricular dysfunction
(RVD), no end organ damage
◦
These data were presented at: Pulmonary EmbolismResponse Team (PERT) 4th Annual Scientific Symposium,PERT Consortium, June 22-23, 2018 (Nashville TN)
⁃
Oral and poster formats
◦
Manuscript in preparation:
⁃
Analyses have been completed examining the effects of treatment with 50mg and 100mg of iv. tPA, and CDI on outcomes of patients with PE from 2012-2017
Dissemination of the findings from this study is expected to guide physicians' decisions and practice regarding PE management
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help